Key result
Clopidogrel safely reduces bleeding vs ticagrelor in NSTE-ACS patients aged 70 or older.
Why the study?
Does clopidogrel reduce bleeding compared with ticagrelor or prasugrel in patients aged 70 years or older with NSTE-ACS?
Does clopidogrel reduce bleeding compared with ticagrelor or prasugrel in patients aged 70 years or older with NSTE-ACS?
In older patients (≥70 years) with NSTE-ACS, clopidogrel reduces bleeding compared to ticagrelor at 1 year.
Supports preferring clopidogrel to reduce bleeding in elderly NSTE-ACS; leaves open randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kelsey et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: